Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel M Geynisman

Showing results (61-70 of 183) with videos related to

Pageof 19
Sort By:
Urologic Oncology|November 28, 2018
Mutations in renal cell carcinomaChristopher D'Avella, Phillip Abbosh, Sumanta K Pal, et al.
Current Treatment Options in Oncology|February 18, 2017
Checkpoint Inhibitors for the Treatment of Renal Cell CarcinomaPooja Ghatalia, Matthew Zibelman, Daniel M Geynisman, et al.
Immunotherapy|June 29, 2016
Checkpoint inhibitors for renal cell carcinoma: current landscape and future directionsMatthew Zibelman, Pooja Ghatalia, Daniel M Geynisman, et al.
Postgraduate Medicine|March 28, 2017
Biosimilar biologic drugs: a new frontier in medical careDaniel M Geynisman, Guillermo De Velasco, K Lea Sewell, et al.
Clinical Advances in Hematology & Oncology : H&O|December 14, 2018
Evolving landscape of the treatment of metastatic clear cell renal cell carcinomaPooja Ghatalia, Matthew R Zibelman, Daniel M Geynisman, et al.
Discovery Medicine|January 1, 2015
Immune checkpoint blockade as a novel immunotherapeutic strategy for renal cell carcinoma: a review of clinical trialsJ Luke Godwin, Matthew Zibelman, Elizabeth R Plimack, et al.
European Urology|January 15, 2018
Chemoimmunotherapy in Metastatic Urothelial CarcinomaDaniel M Geynisman, Phillip H Abbosh, Elizabeth R Plimack, et al.
Translational Andrology and Urology|September 14, 2018
What can the National Cancer Database tell us about disparities in advanced bladder cancer outcomes?Shreyas S Joshi, Elizabeth R Handorf, Marc C Smaldone, et al.
Clinical Genitourinary Cancer|December 3, 2014
Treatment patterns and costs for metastatic renal cell carcinoma patients with private insurance in the United StatesDaniel M Geynisman, Jim C Hu, Lei Liu, et al.
Therapeutic Advances in Medical Oncology|September 27, 2021
Role of immunotherapy in localized muscle invasive urothelial cancerJasmeet Kaur, Woonyoung Choi, Daniel M Geynisman, et al.
Pageof 19

Showing results (61-70 of 183) with videos related to

Sort By:
Pageof 19
Urologic Oncology|November 28, 2018
Mutations in renal cell carcinomaChristopher D'Avella, Phillip Abbosh, Sumanta K Pal, et al.
Current Treatment Options in Oncology|February 18, 2017
Checkpoint Inhibitors for the Treatment of Renal Cell CarcinomaPooja Ghatalia, Matthew Zibelman, Daniel M Geynisman, et al.
Immunotherapy|June 29, 2016
Checkpoint inhibitors for renal cell carcinoma: current landscape and future directionsMatthew Zibelman, Pooja Ghatalia, Daniel M Geynisman, et al.
Postgraduate Medicine|March 28, 2017
Biosimilar biologic drugs: a new frontier in medical careDaniel M Geynisman, Guillermo De Velasco, K Lea Sewell, et al.
Clinical Advances in Hematology & Oncology : H&O|December 14, 2018
Evolving landscape of the treatment of metastatic clear cell renal cell carcinomaPooja Ghatalia, Matthew R Zibelman, Daniel M Geynisman, et al.
Discovery Medicine|January 1, 2015
Immune checkpoint blockade as a novel immunotherapeutic strategy for renal cell carcinoma: a review of clinical trialsJ Luke Godwin, Matthew Zibelman, Elizabeth R Plimack, et al.
European Urology|January 15, 2018
Chemoimmunotherapy in Metastatic Urothelial CarcinomaDaniel M Geynisman, Phillip H Abbosh, Elizabeth R Plimack, et al.
Translational Andrology and Urology|September 14, 2018
What can the National Cancer Database tell us about disparities in advanced bladder cancer outcomes?Shreyas S Joshi, Elizabeth R Handorf, Marc C Smaldone, et al.
Clinical Genitourinary Cancer|December 3, 2014
Treatment patterns and costs for metastatic renal cell carcinoma patients with private insurance in the United StatesDaniel M Geynisman, Jim C Hu, Lei Liu, et al.
Therapeutic Advances in Medical Oncology|September 27, 2021
Role of immunotherapy in localized muscle invasive urothelial cancerJasmeet Kaur, Woonyoung Choi, Daniel M Geynisman, et al.
Pageof 19